Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous haloperidol versus midazolam for conversion disorder symptoms in the emergency department
IRCT2015100712050N2Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of haloperidol and midazolam in Dissociative neurological symptom disorder (DNSD) (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Started Mar 2015; status: completed.
02
Drugs
haloperidolmidazolam
03
Conditions
Dissociative neurological symptom disorder (DNSD)
Beyond the preview
Go deeper on IRCT2015100712050N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015100712050N2.